Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -12,080 | -37,730 | -35,200 | -27,370 |
| Depreciation Amortization | N/A | 7,240 | 6,190 | 5,630 | 4,740 |
| Other Working Capital | N/A | -9,270 | 1,860 | -8,650 | 6,440 |
| Other Operating Activity | 0 | 6,610 | 10,440 | 8,400 | -3,190 |
| Operating Cash Flow | $N/A | $-7,500 | $-19,240 | $-29,820 | $-19,380 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3,520 | -11,220 | -6,300 | -11,170 |
| Other Investing Activity | 0 | 4,430 | -2,010 | 78,960 | 6,670 |
| Investing Cash Flow | $N/A | $910 | $-13,230 | $72,660 | $-4,500 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 8,880 | 3,020 | 5,480 | 21,070 |
| Financing Cash Flow | $N/A | $8,880 | $3,020 | $5,480 | $21,070 |
| Exchange Rate Effect | N/A | -1,570 | 3,930 | 2,480 | -760 |
| Beginning Cash Position | N/A | 26,310 | 51,820 | 1,010 | 4,590 |
| End Cash Position | N/A | 27,020 | 26,310 | 51,820 | 1,010 |
| Net Cash Flow | $N/A | $700 | $-25,510 | $50,800 | $-3,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -7,500 | -19,240 | -29,820 | -19,380 |
| Free Cash Flow | 0 | -7,500 | -19,240 | -29,820 | -19,380 |